ArticleFrontiers in molecular neuroscience2018

The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors.

Inés Reynoso-Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.